Studies on furan derivatives. VII. Reactions of α-(2-furyl)-β-(5- nitro-2-furyl)ethynyl

DOI: 10.1248/cpb.27.3078

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 3078 - 3085 (1979)

Update date:2022-08-02

Topics:

Authors:

Tanaka Tanaka

Usui Usui

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.27.3078

Full text of DOI:10.1248/cpb.27.3078

NII-Electronic Library Service

Products guided by the article

Product name:[2-furan-2-yl-5-methyl-1-(5-nitro-furan-2-yl)-indolizin-3-yl]-phenyl-methanone

Cas No:73916-31-1

R&D Labs maybe for 73916-31-1

Shanghai Yuking Water Soluble Material Tech Co., Ltd

Contact:86-21-68286299

Address:4F, 13B, No. 600, South Xinyuan Road 201306, Shanghai, China
Naturalin Bio-Resource Co., Ltd

website:http://www.naturalin.com

Contact:+86-0731-84430651

Address:B1-402, Lu-Valley Enterprise Square.No.27 Wenxuan Road. Lu-Valley Hi-Tech District.
Chengdu Cogon Bio-tech Co., Ltd.

Contact:86-28-85171192

Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Tianjin SPHINX SCIENTIFIC LAB.

Contact:+86-022-66211289

Address:Tianda high-tech Park. No.80,the 4th Avenue
Guangzhou Chemical Reagent Factory

Contact:+86-20-8435 9820 or 8435 7345

Address:Southern Guangzhou, Guangdong, China

Relevant to this article

Stereoselective Synthesis and Relative and Absolute Configuration of α,1-Bis(4-chlorophenyl)isoindoline-1-ethanol

Doi:10.1021/jo01304a001
(1980)
Virtually complete control of simple and face diastereoselectivity in the Michael addition reactions between achiral equivalents of a nucleophilic glycine and (S)- or (R)-3-(E-enoyl)-4-phenyl-1,3-oxazolidin-2-ones: Practical method for preparation of β-substituted pyroglutamic acids and prolines

Doi:10.1021/jo0495438
(2004)
A concise synthesis of 1-substituted-2-tetralones by selective diol dehydration leading to ketone transposition

Doi:10.1016/S0040-4039(00)01014-5
(2000)
Doi:10.1021/jm00300a061
(1970)
Doi:10.1021/jm00285a027
(1971)
Synthesis of the nucleoside moiety of liposidomycins: Elucidation of the pharmacophore of this family of MraY inhibitors

Doi:10.1016/S0960-894X(00)00349-8
(2000)

Article Doi